Teva Pharmaceutical Industries Ltd. (TEVA)
Sector: | Health Care |
Super Investor Stats: | |
Ownership count: | 5 |
Ownership rank: | 91 |
% of all portfolios: | 0.053% |
Hold Price * : | $16.25 |
History | Portfolio Manager | Activity | Share change | % change to portfolio ▼ | |
Q3  2013 | |||||
≡ | David Katz - Matrix Asset Advisors | Add 20.00% | 9,000 | 0.48 | |
≡ | Thomas Gayner - Markel Group | Add 0.14% | 1,000 | 0.00 | |
Q2  2013 | |||||
≡ | Harry Burn - Sound Shore | Sell 100.00% | 401,300 | 1.01 | |
≡ | Thomas Gayner - Markel Group | Add 5.33% | 35,400 | 0.05 | |
Q1  2013 | |||||
≡ | Harry Burn - Sound Shore | Buy | 401,300 | 1.01 | |
≡ | Thomas Gayner - Markel Group | Add 3.03% | 19,500 | 0.03 | |
Q4  2012 | |||||
≡ | David Katz - Matrix Asset Advisors | Reduce 3.23% | 1,500 | 0.11 | |
≡ | Thomas Gayner - Markel Group | Add 8.12% | 48,400 | 0.08 | |
Q3  2012 | |||||
≡ | David Katz - Matrix Asset Advisors | Reduce 16.96% | 9,500 | 0.68 | |
≡ | Thomas Gayner - Markel Group | Add 7.62% | 42,200 | 0.07 | |
Q2  2012 | |||||
≡ | David Rolfe - Wedgewood Partners | Sell 100.00% | 1,177,319 | 4.29 | |
≡ | David Katz - Matrix Asset Advisors | Add 40.00% | 16,000 | 0.84 | |
≡ | Thomas Gayner - Markel Group | Add 3.15% | 16,900 | 0.03 | |
Q1  2012 | |||||
≡ | David Rolfe - Wedgewood Partners | Add 37.06% | 318,337 | 1.16 | |
≡ | David Katz - Matrix Asset Advisors | Add 37.93% | 11,000 | 0.59 | |
≡ | Thomas Gayner - Markel Group | Add 14.63% | 68,500 | 0.14 | |
Q4  2011 | |||||
≡ | Thomas Gayner - Markel Group | Add 38.41% | 129,900 | 0.28 | |
≡ | David Katz - Matrix Asset Advisors | Add 9.43% | 2,500 | 0.13 | |
Q3  2011 | |||||
≡ | Thomas Gayner - Markel Group | Add 34.15% | 86,100 | 0.20 | |
≡ | David Katz - Matrix Asset Advisors | Add 10.42% | 2,500 | 0.13 | |
Q2  2011 | |||||
≡ | David Katz - Matrix Asset Advisors | Buy | 24,000 | 1.19 | |
≡ | Thomas Gayner - Markel Group | Add 76.79% | 109,500 | 0.28 | |
Q1  2011 | |||||
≡ | Bruce Berkowitz - Fairholme Capital | Sell 100.00% | 177,400 | 0.07 | |
≡ | Thomas Gayner - Markel Group | Add 17.27% | 21,000 | 0.06 | |
Q4  2010 | |||||
≡ | Thomas Gayner - Markel Group | Add 35.87% | 32,100 | 0.09 | |
≡ | Bruce Berkowitz - Fairholme Capital | Buy | 177,400 | 0.07 | |
Q3  2010 | |||||
≡ | Thomas Gayner - Markel Group | Add 48.67% | 29,300 | 0.09 | |
Q2  2010 | |||||
≡ | Thomas Gayner - Markel Group | Add 0.50% | 300 | 0.00 | |
Q1  2010 | |||||
≡ | Thomas Gayner - Markel Group | Buy | 59,900 | 0.23 | |
Q2  2009 | |||||
≡ | Bill & Melinda Gates Foundation Trust | Sell 100.00% | 277,595 | 0.15 | |
Q1  2008 | |||||
≡ | David Katz - Matrix Asset Advisors | Sell 100.00% | 108,000 | 3.13 | |
Q4  2007 | |||||
≡ | David Katz - Matrix Asset Advisors | Reduce 30.10% | 46,500 | 1.35 | |
Q3  2007 | |||||
≡ | David Katz - Matrix Asset Advisors | Reduce 20.77% | 40,500 | 0.88 | |
≡ | Bill & Melinda Gates Foundation Trust | Buy | 277,595 | 0.14 | |
Q2  2007 | |||||
≡ | David Katz - Matrix Asset Advisors | Add 2.09% | 4,000 | 0.07 | |
Q1  2007 | |||||
≡ | David Katz - Matrix Asset Advisors | Reduce 4.98% | 10,000 | 0.20 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.